Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
T follicular helper cells in human efferent lymph retain lymphoid characteristics
Laura A. Vella, … , Michael R. Betts, E. John Wherry
Laura A. Vella, … , Michael R. Betts, E. John Wherry
Published July 2, 2019
Citation Information: J Clin Invest. 2019;129(8):3185-3200. https://doi.org/10.1172/JCI125628.
View: Text | PDF
Research Article Immunology

T follicular helper cells in human efferent lymph retain lymphoid characteristics

  • Text
  • PDF
Abstract

T follicular helper cells (Tfh), a subset of CD4+ T cells, provide requisite help to B cells in the germinal centers (GC) of lymphoid tissue. GC Tfh are identified by high expression of the chemokine receptor CXCR5 and the inhibitory molecule PD-1. Although more accessible, blood contains lower frequencies of CXCR5+ and PD-1+ cells that have been termed circulating Tfh (cTfh). However, it remains unclear whether GC Tfh exit lymphoid tissues and populate this cTfh pool. To examine exiting cells, we assessed the phenotype of Tfh present within the major conduit of efferent lymph from lymphoid tissues into blood, the human thoracic duct. Unlike what was found in blood, we consistently identified a CXCR5-bright PD-1–bright (CXCR5BrPD-1Br) Tfh population in thoracic duct lymph (TDL). These CXCR5BrPD-1Br TDL Tfh shared phenotypic and transcriptional similarities with GC Tfh. Moreover, components of the epigenetic profile of GC Tfh could be detected in CXCR5BrPD-1Br TDL Tfh and the transcriptional imprint of this epigenetic signature was enriched in an activated cTfh subset known to contain vaccine-responding cells. Together with data showing shared TCR sequences between the CXCR5BrPD-1Br TDL Tfh and cTfh, these studies identify a population in TDL as a circulatory intermediate connecting the biology of Tfh in blood to Tfh in lymphoid tissue.

Authors

Laura A. Vella, Marcus Buggert, Sasikanth Manne, Ramin S. Herati, Ismail Sayin, Leticia Kuri-Cervantes, Irene Bukh Brody, Kaitlin C. O’Boyle, Hagop Kaprielian, Josephine R. Giles, Son Nguyen, Alexander Muselman, Jack P. Antel, Amit Bar-Or, Matthew E. Johnson, David H. Canaday, Ali Naji, Vitaly V. Ganusov, Terri M. Laufer, Andrew D. Wells, Yoav Dori, Maxim G. Itkin, Michael R. Betts, E. John Wherry

×

Figure 2

Lymphatic egress is required to maintain cTfh populations in blood.

Options: View larger image (or click on image) Download as PowerPoint
Lymphatic egress is required to maintain cTfh populations in blood.
(A) ...
(A) Time line of blood draws in patients receiving FTY720. (B) Absolute numbers of human CD4+ T cells in the peripheral blood before and 2 and 6 months after FTY720 initiation in patients with multiple sclerosis (n = 6). (C) Fold change in absolute cell numbers at 6 months of therapy compared with pretherapy in CD4+ and CD8+ T cells. (D) Flow cytometric analysis of nonnaive CD4+ T cells over time, with CXCR5+ cells in green boxes, PD-1+ cells in orange boxes, and CXCR5+ PD-1+ cTfh in blue boxes. Frequency for each population noted in matching color. (E and F) Changes in the frequency of CXCR5+ and PD-1+ nonnaive CD4+ T cells over time. (G–I) Changes in the absolute count, frequency, and CXCR5 MFI of cTfh over time. Error is reported as SD. *P < 0.05; **P < 0.01; ***P < 0.001. Friedman’s test was used for data shown in B and E–G. A 2-tailed Student’s t test was performed for data shown in C, and paired t tests were performed for data shown in H and I.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts